
Tatva Chintan Pharma Chem
Tatva Chintan - Chemical Manufacturer, Supplier & Exporter | PTC & QUATS.
Market cap
$300m
Enterprise value
$302m
Share price
INR959.00 TATVA.NS
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
* | N/A | $24.2m | Post IPO Equity |
Total Funding | 000k |

Goldman Sachs(exited)

Abu Dhabi Investment Authority(exited)

Aberdeen Standard Asia Focus(exited)

Malabar India Fund(exited)

Axis Mutual Fund(exited)

ICICI Prudential Mutual Fund(exited)

HDFC Mutual Fund(exited)

SBI Mutual Fund(exited)

Aditya Birla Sun Life AMC(exited)

SBI Life Insurance Company(exited)
INR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 15 % | 45 % | (2 %) | (7 %) | (3 %) | 27 % | 26 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 24 % | 27 % | 16 % | 19 % | 10 % | 17 % | 21 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 18 % | 22 % | 11 % | 8 % | 1 % | 8 % | 11 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads